
Airspace Technologies Announces Strategic Partnership with InVita Healthcare Technologies to Integrate Blood and Plasma Delivery Data During COVID-19 Crisis and Beyond
Read moreRead about what’s going on in our network.
Airspace Technologies Announces Strategic Partnership with InVita Healthcare Technologies to Integrate Blood and Plasma Delivery Data During COVID-19 Crisis and Beyond
Read more“Digital-first workflows that truly automate and connect people across physical boundaries are likely to be big opportunities in software in the next 6-12 months,” Defy Partners senior associate Madison McIlwain said. “Now, more than ever before, people are going to ask the question, ‘Can’t we do this digitally?”‘ Enterprise investors should be seeking opportunities to…
Read moreNautilus Biotechnology, a company that is pioneering high-throughput and low-cost platform for analyzing and quantifying the human proteome, announced it has raised $76 million
Read moreNautilus is uncloaking with a $76 million series B round to do for proteomics—the study of proteins—what companies like Illumnina did for genomics.
Read moreNautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that closed on Monday, May 18, 2020. Nautilus’ total funding now exceeds $100 million.
Read more